Skip to content

Diasorin

Active
Public limited companyfounded 1996active for 29 yearsPaapsemlaan 11, 1070 Anderlecht, Belgium33 active companies are registered at this addressKBO/BCE: BE 0459.475.142
Summary

Diasorin has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.8m and a net result of €2.4m. Equity remains stable across the filed financial years (±1.4% per year). Its solvency ranks better than 19% of 781 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Risk analysisFollow ReportCompare
DiasorinActiveChecked score 77/100
Risk analysis ReportCompare

Overview

Activity
Nutrition and dietetics services
NACE 86995Wholesale of pharmaceutical and medical goods NACE 46460
9th largest company by total assets in Anderlecht, Health and social work sector1 site
Size
€32.0mturnover 2025
Staff
23.9 FTE
Equity
€2.8m
Profit
€2.4m
Financial health
77 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.5%
Structure
Parent
Diasorin S.p.A · 100%
Auditor: PricewaterhouseCoopers Reviseurs d'Entreprises2025 accounts 106 days early
Why 77raises riskLiquidity: current ratio 0.91, cash €5,049Equity €2.8m (15.6% of total assets)1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
77 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 11% of its sector peers (NACE 86, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 41-23
equity 15.6% of total assets
Liquidity 5-16
short-term debt 81.4% · cash 0.0%
Profitability 71-11
return on assets 13.1%
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,075 companies, NACE 86, small)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.2%▲ +0.1 percentage points vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.6%▲ +0.4 percentage points vs 05-2025 07-2025: 0.6%● unchanged vs 06-2025 08-2025: 0.6%● unchanged vs 07-2025 09-2025: 0.6%● unchanged vs 08-2025 10-2025: 0.6%● unchanged vs 09-2025 11-2025: 0.6%● unchanged vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026highest value 04-2026: 0.6%● unchanged vs 03-2026highest value 05-2026: 0.5%▼ -0.1 percentage points vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026 08-2026: 0.5%● unchanged vs 07-2026 09-2026: 0.5%● unchanged vs 08-2026 10-2026: 0.5%● unchanged vs 09-2026
Credit of up to €210,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.91, compared with 1.31 in 2024, below 1; short-term debt: 81.4% and cash: 0% of total assets), and 84.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 9% on solvency, 1% on liquidity, 22% on profitability and 10% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 0.91, cash €5,049
NBB · annual accounts
raises risk · Equity €2.8m (15.6% of total assets)
NBB · annual accounts
raises risk · 1 of the last 3 late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 781 sector peers (2025).
NBB · sector comparison
Position among 781 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-04-2026, 106 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
106 days early
2024
222 days late
2023
103 days early
2022
76 days early
2021
76 days early
2020
87 days early
2019
78 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 43 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 May (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Valerio Giovanni Vaccarone (director)Appointment: Matteo Lombardi (director) ·…
  2. Resignation: Jorge Cereijido Ferreira (director)Appointment: Romuald Courtade (director) ·…
  3. Annual accounts filedfinancial year 2025 · full…

Key points

  • Caution: Equity fell in 2025from €7.7m to €2.8m ▼ 63.8% View
  • Positive: Among the best 5% on net resultsector median €70,927 · 775 companies €2.4m View
  • Board changedlatest change 22-05-2026 · 3 in office 2 joined · 2 left View
  • Positive: 8 profitable years in a rowprofit 2025: €2.4m 8 years View
  • Controlled by Diasorin S.p.A 100% View

By topic

Financials

Financial year
2025
Turnover
€32.0m
Profit
€2.4m
Solvency
15.6%
Turnover▼ 2.3%
Net result
20182025
Go to Financials

Board & ownership

Board
3 members
Parent
Diasorin S.p.A · 100%
Auditor
PricewaterhouseCoopers Reviseurs d'Entreprises
  • Barbara RocchiDirector
  • Romuald CourtadeManaging director
  • Matteo LombardiDirector
Go to Board & ownership

Timeline

Events
59
Since
1998
Next accounts
by 31-07-2027
  1. 13-03-2026Reappointment: EY Réviseurs d'Entreprises SRL (statutory auditor)
  2. 10-03-2026Annual accounts filed
  3. 15-01-2026Resignation: Halmar de Rooij (représentant permanent de…
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Nutrition and dietetics servicesNACE 86995
Founded
17-12-1996
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
19
Annual meeting
Third Wednesday of April at 17:00
Purpose
“L’importation,l’exportation,la vente en Belgique,la mise au point,l’installation et…” (deed in French)
Go to Articles of association

Key facts about Diasorin

What is the company number of Diasorin?
0459.475.142. In Belgium the VAT number is the company number with BE in front: BE 0459.475.142.
Where is Diasorin based?
The registered office is at Paapsemlaan 11, 1070 Anderlecht.Company details
What does Diasorin do?
According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
What is the legal form of Diasorin?
Public limited company (NV).
When was Diasorin founded?
On 17-12-1996.
Is Diasorin still active?
Yes, Diasorin is an active enterprise in the KBO register.
How many employees does Diasorin have?
On average 23.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Diasorin?
€32.0m in financial year 2025, according to the filed annual accounts.
Is Diasorin profitable?
In financial year 2025, Diasorin made a profit of €2.4m.
Where can I find the annual accounts of Diasorin?
Diasorin filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Diasorin due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Diasorin

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure